NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science
In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General
“Our Job Is to Be The One Agency That Speaks To Cancer”
“The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts”
NCABP “Anyone With Same Facts Would Have Come To Same Conclusion
Prevention Trial Could Stand On Its Own
Chabner : Opportunity To Set Own Agenda Reason For Leaving
Trending Stories
- As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer
- Trump 2016: A look back at the 45th president’s impact on oncology
- Ready or not, AI-based decision support tools are entering oncology clinics
Regulators and health systems must adapt - As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research - Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.”